Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEFINITY for Poor Echocardiographic Imaging Quality (China, Phase III)
CTR20170851Phase 3Completed
- Sponsor
- Lansource Medical Imaging
- Start
- Aug 2017
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of perflutren lipid microspheres, sponsored by Lansource Medical Imaging. Started Aug 2017; status: completed.
02
Drugs
perflutren lipid microspheres
Beyond the preview
Go deeper on CTR20170851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170851.